Galaxy Ring’s FDA Sleep Apnea Clearance Faces a Familiar Wait

Samsung confirmed at Galaxy Unpacked in London on July 22 that the Galaxy Ring will get FDA-cleared sleep apnea risk detection this fall, a first for any smart ring on the market. Samsung has not named an exact date. Its own Galaxy Watch took roughly five months to go from that same kind of clearance to actually reaching wrists.

That gap matters more than the celebratory framing suggests. The regulatory door Samsung just walked through is also now open to Oura, RingConn and anyone else who wants to follow the same path, which means the exclusivity Samsung is marketing today has a shelf life nobody has put a number on yet.

Samsung Confirms FDA Clearance for the Galaxy Ring

Sharanya Desai, Samsung’s head of digital health, delivered the news almost as an aside during a segment about the Galaxy Watch 9’s health tools. Samsung’s Unpacked event drew attention mostly for the Galaxy Z Flip 8, Z Fold 8 and Z Fold 8 Ultra, plus the new Watch 9 and Watch Ultra 2, which run on Galaxy Watch 9’s switch to a Qualcomm chip for the first time.

Desai’s sleep apnea line landed with more consequence than most of the hardware news.

Galaxy Ring will be the first and only FDA-cleared over-the-counter ring device for sleep apnea risk detection.

That was Desai, speaking on stage at Unpacked. Samsung says the ring will likely rely on the same underlying approach as the Watch: tracking blood oxygen levels overnight and using an AI algorithm to estimate a wearer’s Apnea-Hypopnea Index, the average number of times breathing stops or turns shallow in an hour. The company hasn’t detailed the ring’s exact sensor setup, but it has been explicit that the tool flags risk. It does not diagnose sleep apnea, and anyone flagged is meant to see a doctor for confirmation.

Left untreated, sleep apnea carries real consequences. Estimates put the number of people affected globally at over 1 billion, and the condition is linked to higher risk of high blood pressure, heart failure and irregular heartbeat.

Oura and RingConn Track Breathing, Not Risk

Samsung’s claim to being first checks out against the current field. Other smart rings offer overnight breathing insights, but none carry the same regulatory label.

Neither Oura nor RingConn markets its breathing tools as FDA-cleared, and Samsung’s own Watch already costs up to $500 depending on the model. A ring that does the same job at a lower price point is a real pitch to shoppers who want the feature without the smartwatch price tag.

How Long the Watch Actually Took to Arrive

Samsung’s sleep apnea story didn’t start this month. It started in 2023, and it moved slower than the current rollout promise suggests.

1. May 2023: Samsung files its FDA De Novo request for the Galaxy Watch’s sleep apnea feature.
2. October 2023: South Korea’s Ministry of Food and Drug Safety clears the feature first, ahead of any US decision.
3. February 6, 2024: The FDA grants De Novo authorization after an eight-month review, and Samsung announces it days later.
4. Third quarter of 2024: The feature begins reaching Galaxy Watch 4 and newer devices in the US, with fuller rollout extending well into the following year.
5. September 13, 2024: Apple wins its own 510(k) clearance for the Apple Watch’s version of the feature.
6. July 22, 2026: Samsung confirms FDA clearance for the Galaxy Ring at Unpacked in London.
7. Fall 2026: The Ring’s sleep apnea detection is expected to go live, with no specific date confirmed.

Add it up and the Watch needed close to a year from South Korean approval to landing on wrists in the US, and longer still before every eligible owner had it. Samsung is now promising the Ring will do something similar in a fraction of that window.

Apple Cleared the Same Hurdle in Days

The comparison isn’t hypothetical. Apple announced on September 9, 2024, that its own sleep apnea notification feature pending FDA clearance would arrive later that month. The FDA cleared it four days later, and the feature was live on Apple Watch Series 9, Series 10 and Ultra 2 within about a week of the announcement.

Dr. David Kuhlmann, a Missouri physician who has treated sleep disorders for nearly two decades and sits on the American Academy of Sleep Medicine’s board, said Apple’s feature was potentially a game changer for patients reluctant to seek testing. He also cautioned that wearable readings could be erroneous and said insurers were unlikely to reimburse based on a wearable flag alone. Apple’s speed proved that clearance to consumer availability doesn’t have to take months. Samsung’s own history says it usually does.

Samsung’s Track Record Complicates Its Own Promise

Samsung isn’t only adding health features to US wearables this year. It’s also removing one. The company is pulling its vascular load feature from US watches, a reminder that a health capability landing on a Samsung device in America isn’t always permanent, let alone fast.

That history cuts against the tidy version of this story. Samsung hasn’t said whether the Ring’s feature will use the exact same algorithm validated for the Watch or a modified version needing its own review. If it’s the former, a faster rollout is plausible. If it’s the latter, the eight-month wait the Watch went through could repeat itself.

What Does the FDA Clearance Actually Cover?

Samsung’s FDA clearance is narrower than the marketing suggests: it covers adults 22 and older who haven’t been previously diagnosed with sleep apnea, requires two nights of tracking within a 10-day window, and flags only moderate to severe cases, never central sleep apnea. The clearance is a risk flag, not a diagnosis.

The original FDA authorization for the Watch feature spells out exactly who it’s for and who it isn’t.

• Age minimum – users must be 22 or older to use the feature.
• No prior diagnosis – the tool is not intended for users already diagnosed with sleep apnea.
• Monitoring window – Samsung’s Watch version asks users to track sleep twice for more than four hours within a ten-day period.
• Severity ceiling – it detects moderate to severe obstructive sleep apnea only, and cannot flag central sleep apnea.
• Not a replacement – results are meant to prompt a clinician visit, not substitute for a formal diagnosis.

That is not unusual for a consumer wearable claim. But it does mean the “leg up on rivals” framing applies to a fairly specific slice of buyers, not everyone shopping for a sleep tracker.

Rivals Now Have a Faster Path to Follow

The FDA’s 2024 decision on Samsung’s Watch didn’t just clear one product. It created a new device category, an over-the-counter tool to assess sleep apnea risk, and set special controls that other companies can use to seek their own clearance through a faster substantial equivalence review rather than starting a De Novo process from scratch.

That’s the part of this story that undercuts Samsung’s exclusivity pitch. Oura and RingConn haven’t filed for that clearance yet, as far as public records show, but the path Samsung paved is available to them now. The same kind of regulatory groundwork exists in other markets too. Digital health device makers overseas face their own version of this friction, as clearing the EU’s toughest device rule recently cost one smaller medtech firm months of review before it could raise fresh funding.

Samsung has not named an exact date beyond fall. Its own Watch took roughly five months to go from FDA paperwork to consumer wrists, and fall itself runs only through November.

Frequently Asked Questions

What is the Apnea-Hypopnea Index, and why does it matter?

The Apnea-Hypopnea Index, or AHI, measures how many times an hour a person’s breathing stops or becomes shallow during sleep. Samsung’s Watch estimates it using blood oxygen data pulled from its BioActive sensor, and the Ring is expected to use a similar calculation once its version of the feature goes live.

Can other smart rings get the same FDA clearance?

Yes, in theory. The FDA’s 2024 authorization for Samsung’s Watch created a generic device category with special controls attached, meaning other companies can seek clearance by showing their product works the same way, a faster process than the original review Samsung went through. Oura and RingConn have not publicly pursued it yet.

Does a risk alert mean a confirmed sleep apnea diagnosis?

No. A flagged result is meant to send a user to a doctor for an actual sleep study. Traditional at-home sleep apnea tests still run in the hundreds of dollars, with one widely used option from Sleep Doctor priced at $189, so a wearable-based flag is a cheaper first step, not a replacement for clinical testing.

Does the Galaxy Ring need a Galaxy phone or watch to work?

Samsung hasn’t detailed the exact device requirements for the Ring’s version of the feature. The Watch’s clearance covers software running on a paired Galaxy Watch and phone through the Samsung Health Monitor app, so a similar phone pairing for the Ring is likely, though Samsung has not confirmed whether a Watch is also required.

Disclaimer: This article is for informational purposes only and does not constitute medical advice; sleep apnea risk detection on any wearable is not a diagnostic tool, and readers with concerns should consult a licensed physician. Figures are accurate as of publication.